24259-15-2

Upstream product

• 145450-39-1 2-phenyl-2-cyclohexene-1-carbonyl chloride 
• 120-29-6 3-tropanol 
• 23153-80-2 1,4-dioxaspiro[4.5]dec-6-yl-methanol 
• 13747-72-3 ethyl 1,4-dioxa-spiro[4,5]decane-6-carboxylate 
• 1655-07-8 ethyl 2-oxocyclohexane carboxylate 
• 24927-50-2 2-Hydroxymethyl-1-phenyl-cyclohexanol 
• 21472-50-4 2-hydroxy-2-phenyl-cyclohexanecarboxylic acid 
• 24102-01-0 2-phenylcyclohex-2-ene-1-carboxylic acid 
• 5331-08-8 2-(hydroxymethyl)cyclohexanone 

Downstream Products

• 145449-99-6 endo-syn-8-methyl-8-(1-methylethyl)-3-<<2-phenyl-2-cyclohexene-1-yl)-carbonyl>oxy>-8-azoniabicyclo<3.2.1>octane iodide 
• 145449-77-0 endo-syn-8-(1-methylethyl)-8-methyl-3-<<(2-phenyl-2-cyclohexene-1-yl)-carbonyl>oxy>-8-azoniabicyclo<3.2.1>octane iodide 
• 145449-80-5 (1S,3R,5R,8S)-8-Butyl-8-methyl-3-(2-phenyl-cyclohex-2-enecarbonyloxy)-8-azonia-bicyclo[3.2.1]octane; iodide 
• 145449-79-2 (1S,3R,5R,8S)-8-Isobutyl-8-methyl-3-(2-phenyl-cyclohex-2-enecarbonyloxy)-8-azonia-bicyclo[3.2.1]octane; iodide 
• 675868-79-8 (1R,3R,5S)-3-(2-Phenyl-cyclohex-2-enecarbonyloxy)-8-aza-bicyclo[3.2.1]octane-8-carboxylic acid 1-chloro-ethyl ester 
• 675868-95-8 ethyl 2-[8-aza-3-(2-phenylcyclohex-2-enylcarbonyloxy)bicyclo[3.2.1]oct-8-yl]acetate 
• 675868-83-4 methyl 2-[8-aza-3-(2-phenylcyclohex-2-enylcarbonyloxy)bicyclo[3.2.1]oct-8-yl]acetate 
• 675868-81-2 8-azabicyclo[3.2.1]oct-3-yl 2-phenylcyclohex-2-enecarboxylate 
• 145450-27-7 endo-8-methyl-8-azabicyclo<3.2.1>oct-3-yl cis-2-phenyl-cyclohexanecarboxylate 
• 145449-78-1 (1S,3R,5R,8S)-8-Methyl-3-(2-phenyl-cyclohex-2-enecarbonyloxy)-8-propyl-8-azonia-bicyclo[3.2.1]octane; iodide 
• 145449-75-8 (1S,3R,5R,8S)-8-Ethyl-8-methyl-3-(2-phenyl-cyclohex-2-enecarbonyloxy)-8-azonia-bicyclo[3.2.1]octane; iodide 

Relevant academic research and scientific papers

Design, Pharmacokinetic, and Pharmacodynamic Evaluation of a New Class of Soft Anticholinergics

Purpose. To design and evaluate a new class of soft anticholinergics with subtype selectivity. Methods. A new class of soft anticholinergics was designed based on the "inactive metabolite" approach. Four compounds were synthesized. The potency and soft na

N-Alkyl-nor-tropine esters of 2-phenyl-cyclohexenic acids as new bronchodilator agents. Effect of structural and conformational modifications on affinity for muscarinic receptors

A series of N-alkyl-nor-tropine esters of 2-phenyl-2-cyclohexene-1-carboxylic, 2-phenyl-cyclohexanecarboxylic, and 2-phenyl-1-cyclohexene-1-acetic acids and their quaternary ammonium salts were synthesized and evaluated for bronchodilator activity by bind